E. coli infections could be reduced with probiotics, show non-human studies

By Shane Starling

- Last updated on GMT

Related tags E. coli Escherichia coli

E. coli infections could be reduced with probiotics, show non-human studies
The recent spate of 1000s of E. coli infectionsin Europe – with no known treatment – that sprang from contaminated vegetables could be reduced in occurrence and severity by probiotics, in vitro trials demonstrate.

There is no cure for E. coli infections such as those that adhere to epithelial cells in the gut (enterohemorrhagic E. coli - or EHEC), but probiotic supplier Winclove Bio Industries is highlighting existing non-human research that explores probiotic potential in the area.

While the Dutch supplier acknowledges the data so far collected is purely in vitro​, such results bear closer scrutiny given ‘the E. coli crisis’ that saw about 50 people die, and was followed by the European Union stumping up €210m to boost the hard-hit fruit and vegetable sector in the wake of the crisis.

Typical symptoms of the problem are abdominal cramps and watery or bloody diarrhoea which can lead to hemolytic-uremic syndrome (HUS), which can shut down the kidneys. It is most common in children and the elderly.

While the recent infections were caused by the E. coli strain 0104:H4, whereas most of the in vitro work has been performed another E. coli variant: 0157:H7. But the encouraging anti-adhesion results there gave merit to exploring probiotic effects for 0104:H4.

“In vitro studies have shown that probiotics may be effective in controlling infections caused by E. coli 0157:H7 on all three levels,”​ Winclove said. Those levels are microbial interaction; epithelium interaction and immune system interaction.

Bifidobacteria​ and Lactibacillus​ strains had shown the most potential.

For example, L. acidophilus​ had been shown to positively effect the upregulation of intestinal tract mucins and the subsequent inhibition of attachment of E. coli 0157:H.

Winclove said: “The discussed results have not been obtained from experiments in humans, however it is reasonable to assume that at least some of these results can be extrapolated. Therefore, it is worthwhile investigating the probiotic capabilities to control the [toxin] production and disease symptoms caused by E. coli 0104:H4 in human gut cells.”

Cytoskeletal rearrangements

Rather than invading gut mucosa, EHEC can induce cytoskeletal rearrangements in infected epithelial cells leading to lesions that alter intestinal permeability.

HUS is thought to be caused by the Shiga toxins that are transported through the bloodstream by neutrophils binding to target cell surface receptors resulting into cell apoptosis, Winclove observed.

Related news

Related products

show more

Whitepaper: Discover a new era in postbiotics

Whitepaper: Discover a new era in postbiotics

Content provided by DSM Nutritional Products | 28-Nov-2023 | White Paper

Postbiotic ingredients are set to open up a world of opportunities across the human health and nutrition industry, fueled by developing science demonstrating...

Taking Immune Support to a New Level

Taking Immune Support to a New Level

Content provided by AB Biotek Human Nutrition & Health | 30-Oct-2023 | White Paper

Patent-pending ABB C1® redefines immune support by addressing innate, acquired, and Trained Immunity. In 'ABB C1®: Training Now for Future Immune...

Custom Biotic Solutions for Digestive Health

Custom Biotic Solutions for Digestive Health

Content provided by ADM: Innovation that Feeds the Future | 10-Oct-2023 | White Paper

A growing body of evidence shows gut health can affect digestive health, well-being, and many health areas in between.

Related suppliers

Follow us


View more